Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/4361
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Angucyclinones related to Ochromycinone. IV. The structures and reactions of unusual Diels-Alder Adducts formed from Maleic Anhydride and Racemic 5,5-Dimethyl-3-vinylcyclohex-2-en-1-ol
Author: Brinkworth, C.
Rozek, T.
Bowie, J.
Skelton, B.
White, A.
Citation: Australian Journal of Chemistry, 2000; 53(5):403-409
Publisher: C S I R O Publishing
Issue Date: 2000
ISSN: 0004-9425
Statement of
Responsibility: 
Craig Brinkworth, Tomas Rozek, John H. Bowie, Brian W. Skelton and Allan H. White
Abstract: The Diels–Alder reaction between maleic anhydride and racemic 5,5-dimethyl-3-vinylcyclohex-2-en-1-ol gives two racemic diastereomers, the major product (2a,S,3R,8aS,8bR)-7,7-dimethyl-2-oxo-2a,3,4,6,7,8,8a,8b-octahydro-2H-benzo[cd]isobenzofuran-3-carboxylic acid (63% yield), and the minor product (2aR,3S,8aS,8bS)-7,7-dimethyl-2-oxo-2a,3,4,6,7,8,8a,8b-octahydro-2H-benzo[cd]isobenzofuran-3-carboxylic acid (9%). Epoxidation of the major product gives racemic (1aS,3R,3aS,5aR,8aS,8bR)-7,7-dimethyl-4 oxoperhydro-benzo[cd]oxireno[2,3-e]isobenzofuran-3-carboxylic acid in 81% yield, while opening of the epoxide ring gave the trans diol (2aS,3R,5S,5aR,8aR,8bR)-5,5a-dihydroxy-7,7-dimethyl-2-oxoperhydrobenzo[cd]isobenzofuran-3-carboxylic acid in 58% yield. Treatment of the major Diels–Alder product with osmium tetraoxide gave the cis diol (2aS,3R,5S,5aR,8aS,8bR)-5,5a-dihydroxy-7,7-dimethyl-2-oxoperhydrobenzo[cd]isobenzofuran-3-carboxylic acid in 86% yield. The structures of four products were confirmed by X-ray and n.m.r. methods. None of the products exhibit anticancer activity.
Keywords: Diels– Alder reaction; oxidation; synthesis; X-ray crystal structure
Description: Copyright © 2000 CSIRO
RMID: 0001000361
DOI: 10.1071/CH00034
Appears in Collections:Chemistry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.